» Authors » Bartosz Slominski

Bartosz Slominski

Explore the profile of Bartosz Slominski including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 92
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Maciejewska A, Czernia P, Piotrowska-Mieczkowska M, Wajda B, Slominski B, Romantowski J, et al.
Front Immunol . 2025 Jan; 15():1436491. PMID: 39845961
Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease, characterized by impaired wound repair, tissue remodeling and fibrosis. Immune system may participate in the development and progression of the...
2.
Karczewska M, Wang A, Narajczyk M, Slominski B, Szalewska-Palasz A, Nowicki D
Phytomedicine . 2024 Jul; 132:155845. PMID: 38964154
Background: Compounds of natural origin are potent source of drugs with unique mechanisms of action. Among phytochemicals, trans-cinnamaldehyde (t-CA) exhibits a wide range of biological activity, thus has been used...
3.
Ryba-Stanislawowska M, Slominski B, Mysliwiec M
Diabetes Obes Metab . 2024 Jun; 26(9):3663-3672. PMID: 38894632
Aim: To explore the potential association between the KLF14 rs4731702 polymorphism and metabolic syndrome traits among patients diagnosed with type 1 diabetes (T1D). Methods: The study group included 350 patients...
4.
Slominski B, Skrzypkowska M, Mysliwiec M, Trzonkowski P
Diabetes Res Clin Pract . 2024 Apr; 211:111683. PMID: 38663549
Background And Aims: Because FTO gene is connected with the risk of obesity, cardiovascular disease and hypertension, as well as type 2 diabetes, we hypothesize that the rs9939609 FTO polymorphism...
5.
Slominski B, Skrzypkowska M, Mysliwiec M, Trzonkowski P
Neuroendocrinology . 2023 Apr; 113(8):875-884. PMID: 37080173
Introduction: Because dopaminergic signaling pathways are one of the regulators of autoimmunity, we hypothesize that the -521C>T DRD4 gene polymorphism may associate with the risk of diabetes mellitus type 1...
6.
Slominski B, Jankowiak M, Maciejewska A, Studzinski M, Maczynska A, Skrzypkowska M, et al.
Cytokine . 2022 Sep; 160:156025. PMID: 36122502
Background And Aims: Elevated concentration of CRP has been associated with the risk of diabetes as well as cardiovascular events and microvascular complications in T1D patients. We hypothesize that the...
7.
Skrzypkowska M, Stasiak M, Sakowska J, Chmiel J, Maciejewska A, Bucinski A, et al.
Rheumatol Int . 2022 Feb; 42(4):609-619. PMID: 35179632
Rheumatoid arthritis is a severe chronic autoimmune disorder that results from pathological activation of immune cells and altered cytokine/chemokine network. The aim of our study was to evaluate concentrations of...
8.
Bochenska K, Moskot M, Smolinska-Fijolek E, Jakobkiewicz-Banecka J, Szczerkowska-Dobosz A, Slominski B, et al.
Sci Rep . 2021 Sep; 11(1):18297. PMID: 34521933
Genistein is applied worldwide as an alternative medicament for psoriasis (Ps) because of its anti-inflammatory activity and perceived beneficial impact on the skin. Hereby, we report our in vivo and...
9.
Fichna M, Zurawek M, Slominski B, Suminska M, Czarnywojtek A, Rozwadowska N, et al.
Endocrine . 2021 May; 74(1):72-79. PMID: 33966174
Purpose: Genetically predisposed individuals may develop several autoimmune diseases-autoimmune polyendocrine syndromes (APS). APS types 2-4, are complex disorders, which combine various organ-specific autoimmune conditions. Recent reports support the considerable role...
10.
Slominski B, Skrzypkowska M, Ryba-Stanislawowska M, Mysliwiec M, Trzonkowski P
J Mol Med (Berl) . 2021 Jan; 99(5):675-683. PMID: 33495869
Wild-type TP53 plays an important role in the regulation of immune response and systemic inflammation. In type 1 diabetes (T1D), TP53 pathways are upregulated and an increased susceptibility to apoptosis...